Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo.
about
Omega-3 Fatty Acids and Cancer Cell Cytotoxicity: Implications for Multi-Targeted Cancer Therapy15-Lipoxygenase-1-mediated metabolism of docosahexaenoic acid is required for syndecan-1 signaling and apoptosis in prostate cancer cellsThe influence of Cox-2 and bioactive lipids on hematological cancers.Biochemical Characterization of Liver Oil of Echinorhinus brucus (Bramble Shark) and Its Cytotoxic Evaluation on Neuroblastoma Cell Lines (SHSY-5Y)Preoperative serum docosahexaenoic acid level predicts prognosis of renal cell carcinoma.Characterization of docosahexaenoic acid (DHA)-induced heme oxygenase-1 (HO-1) expression in human cancer cells: the importance of enhanced BTB and CNC homology 1 (Bach1) degradation.Secreted protein acidic and rich in cysteine (SPARC) induces lipotoxicity in neuroblastoma by regulating transport of albumin complexed with fatty acids.Essential fatty acids and their metabolites as modulators of stem cell biology with reference to inflammation, cancer, and metastasis.The multifaceted effects of omega-3 polyunsaturated Fatty acids on the hallmarks of cancer.Low-density lipoprotein-mediated delivery of docosahexaenoic acid selectively kills murine liver cancer cellsInhibition of neuroblastoma cell proliferation with omega-3 fatty acids and treatment of a murine model of human neuroblastoma using a diet enriched with omega-3 fatty acids in combination with sunitinib.Docosahexaenoic acid (DHA) promotes immunogenic apoptosis in human multiple myeloma cells, induces autophagy and inhibits STAT3 in both tumor and dendritic cells.Dietary ω -3 polyunsaturated fatty acid DHA: a potential adjuvant in the treatment of cancer.
P2860
Q26773056-D586B8D3-BBF8-4FA0-92E6-B8AD24008279Q28277101-D5D878F7-6362-4BFA-8AC8-936E2759C58FQ33688673-383DC23F-4B77-4450-9CA8-1FE4C1E8091DQ37000216-CADE6A36-0F8F-4E7A-96C2-2BEADC36797FQ37000922-B6F71E6E-E4F7-42EB-9F60-B988CEF57017Q37705221-C5DBD4D5-99A5-42E2-924A-B3C9752F83E7Q37718422-BB809D66-41BB-4443-86DA-D2A630B708CAQ37946729-51885F63-84EF-4739-9247-CD368C917AF6Q38114076-5D713F6E-DB55-464F-A883-F6A572AFC486Q39036813-4BBB544F-13BD-4FE7-A739-65BB71BE87A7Q39410149-3A569AB3-03BD-4A69-8533-E985DC57549BQ41785517-F39EE6AC-4FE2-4B49-A838-C2507E51822AQ42146247-A4EBCCD3-865B-4A4A-B8B3-DC49ABF9801F
P2860
Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo.
@en
Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo.
@nl
type
label
Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo.
@en
Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo.
@nl
prefLabel
Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo.
@en
Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo.
@nl
P2093
P2860
P356
P1476
Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo.
@en
P2093
Frida Ponthan
Helena Gleissman
John Inge Johnsen
Lova Segerström
Magnus Lindskog
Mats Hamberg
Per Kogner
P2860
P304
P356
10.1002/IJC.25473
P577
2010-05-24T00:00:00Z